Literature DB >> 19890625

The impact of crystalloid and colloid infusion on the kidney in rodent sepsis.

Martin Alexander Schick1, Tobias Jobst Isbary, Nicolas Schlegel, Juergen Brugger, Jens Waschke, Ralf Muellenbach, Norbert Roewer, Christian Wunder.   

Abstract

PURPOSE: Volume replacement remains one of the pillars of sepsis therapy. The effect of different volume solutions on kidney function in sepsis still remains unclear. We therefore determined the impact of crystalloid and colloid solutions on kidney function in a rodent model of abdominal sepsis induced by cecal ligation and puncture (CLP).
METHODS: Anesthetized rats underwent the CLP procedure, whereas control animals were sham operated. Septic animals were treated with crystalloid and colloid solutions. Hemodynamic variables and blood gases were measured. After 24 h animals were re-anesthetized, the kidneys were harvested, and creatinine (crea), urea, cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) were investigated.
RESULTS: Septic animals exhibited a mortality rate of 19% after 24 h. Gelatin-treated animals showed significantly increased levels of crea and urea. Colloids [gelatin 4% (Gel) or hydroxyethyl starch 6% 130/0.4 (HES)] as volume replacement resulted in elevated levels of NGAL. The histopathological observations revealed that Gel- and HES-treated animals showed vesicles within epithelial cells of the tubulus system and an overall increased injury. In contrast, total injury scores in groups treated with crystalloids [0.9% NaCl (NaCl) and Sterofundin ISO (SteroIso)] were not significantly different compared to sham-treated animals.
CONCLUSION: None of the examined volume solution was inert to the kidney. In a CLP rodent sepsis model, animals infused with balanced crystalloid SteroIso exhibited the least effects on kidney function. Both hydroxyethyl starch 6% 130/0.4 and gelatin 4% derogated the kidney, whereas gelatin was more harmful when compared with hydroxyethyl starch.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890625     DOI: 10.1007/s00134-009-1704-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

1.  [Base excess and lactate concentration in infusion solutions and blood products].

Authors:  R Zander
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2002-06       Impact factor: 0.698

Review 2.  Identification of renal injury in cardiac surgery: the role of kidney-specific proteins.

Authors:  Joachim Boldt; Michael Wolf
Journal:  J Cardiothorac Vasc Anesth       Date:  2007-12-31       Impact factor: 2.628

3.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

4.  The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients.

Authors:  Joachim Boldt; Stephan Suttner; Christian Brosch; Andreas Lehmann; Kerstin Röhm; Andinet Mengistu
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

Review 5.  Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature.

Authors:  Emanuel P Rivers; Victor Coba; Melissa Whitmill
Journal:  Curr Opin Anaesthesiol       Date:  2008-04       Impact factor: 2.706

Review 6.  Volume replacement in critically ill patients with acute renal failure.

Authors:  M J Ragaller; H Theilen; T Koch
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

7.  Renal handling of radiolabelled human cystatin C in the rat.

Authors:  O Tenstad; A B Roald; A Grubb; K Aukland
Journal:  Scand J Clin Lab Invest       Date:  1996-08       Impact factor: 1.713

Review 8.  Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease.

Authors:  Prasad Devarajan
Journal:  Scand J Clin Lab Invest Suppl       Date:  2008

Review 9.  [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].

Authors:  S Suttner; J Boldt
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2004-02       Impact factor: 0.698

Review 10.  Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Authors:  P Perel; I Roberts
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  25 in total

Review 1.  [Volume replacement in intensive care medicine].

Authors:  B Nohé; A Ploppa; V Schmidt; K Unertl
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

2.  [Update on intensive care medicine. Most important publications from 2012-2014].

Authors:  J Knapp; M Bernhard; S Hofer; E Popp; M A Weigand
Journal:  Anaesthesist       Date:  2014-05       Impact factor: 1.041

Review 3.  Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?

Authors:  Christiane S Hartog; Frank M Brunkhorst; Christoph Engel; Andreas Meier-Hellmann; Maximilian Ragaller; Tobias Welte; Evelyn Kuhnt; Konrad Reinhart
Journal:  Wien Klin Wochenschr       Date:  2011-03-01       Impact factor: 1.704

Review 4.  Fluid replacement with hydroxyethyl starch in critical care--a reassessment.

Authors:  Christiane S Hartog; Tobias Welte; Peter Schlattmann; Konrad Reinhart
Journal:  Dtsch Arztebl Int       Date:  2013-06-28       Impact factor: 5.594

5.  Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation.

Authors:  Martin Alexander Schick; Christian Wunder; Jakob Wollborn; Norbert Roewer; Jens Waschke; Christoph-Thomas Germer; Nicolas Schlegel
Journal:  J Physiol       Date:  2012-04-10       Impact factor: 5.182

6.  Comparison of two fluid solutions for resuscitation in a rabbit model of crush syndrome.

Authors:  De-yang Kong; Li-rong Hao; Li Zhang; Qing-gang Li; Jian-hui Zhou; Suo-zhu Shi; Fei Zhu; Yan-qiu Geng; Xiang-mei Chen
Journal:  Clin Exp Nephrol       Date:  2015-04-25       Impact factor: 2.801

7.  Early murine polymicrobial sepsis predominantly causes renal injury.

Authors:  Florin L Craciun; Kendra N Iskander; Evan L Chiswick; David M Stepien; Joel M Henderson; Daniel G Remick
Journal:  Shock       Date:  2014-02       Impact factor: 3.454

8.  Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentals.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-01-04       Impact factor: 17.440

9.  Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury.

Authors:  Boris Betz; Reinhard Schneider; Tobias Kress; Martin Alexander Schick; Christoph Wanner; Christoph Sauvant
Journal:  PPAR Res       Date:  2012-02-15       Impact factor: 4.964

10.  Effects of crystalloids and colloids on liver and intestine microcirculation and function in cecal ligation and puncture induced septic rodents.

Authors:  Martin Alexander Schick; Jobst Tobias Isbary; Tanja Stueber; Juergen Brugger; Jan Stumpner; Nicolas Schlegel; Norbert Roewer; Otto Eichelbroenner; Christian Wunder
Journal:  BMC Gastroenterol       Date:  2012-12-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.